Focus Partners Wealth
DTIL icon

Focus Partners Wealth’s Precision BioSciences DTIL Stock Holding History

Focus Partners Wealth’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Buy
+19,111
New +$88.2K ﹤0.01% 2505

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Focus Partners Wealth's DTIL Position: Q1 2026 in Review

Focus Partners Wealth opened a new position in Precision BioSciences (DTIL) in Q1 2026: 19,111 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #2505 among its holdings.

78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Focus Partners Wealth held 19,111 shares of Precision BioSciences worth $105K as of Q1 2026.
  • Precision BioSciences was a new Focus Partners Wealth position in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2505 holding.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.